Relvar Ellipta
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Relvar Ellipta, covering 2018-10-23 to 2025-04-10. Get the full timeline:
Most recent: EMA Authorised: Relvar Ellipta (fluticasone furoate;vilanterol) — GlaxoSmithKline Trading Services Limited